Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies effectively treat acne and improve quality of life.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Bicalutamide shows promise for treating female hair loss.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Finasteride may not affect gynecomastia recurrence after mastectomy.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.